Detailed price information for Biocryst Pharma Inc (BCRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

The global allogeneic cell therapy market is set to witness a growth rate of 25% in the next 5 years. Growing demand for ...

Kingsview Wealth Management recently bought a new stake in Vertex Pharmaceuticals. They snagged 545 shares, valued around ...

Investors will focus on profits from asthma drug Dupixent and sales of Eylea HD when biotech giant Regeneron Pharmaceuticals, ...

The gene editing market represents one of the most transformative sectors in modern biotechnology, fundamentally reshaping how we approach genetic diseases, agricultural development, and therapeutic ...

UBS Group recently trimmed its price target on Lockheed Martin from $498.00 to $453.00, hinting at nuanced shifts in the aerospace sector's financial landscape. The revised target suggests a potential ...